Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-04-17

FDA Approved: CLOBETASOL PROPIONATE — Original Application (Xiromed, LLC)

View source ↗

Summary

FDA approved the original application for clobetasol propionate (topical) by Xiromed, LLC. It is a potent corticosteroid indicated for corticosteroid-responsive…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLOBETASOL PROPIONATE (Clobetasol propionate)

Snippet

ORIG AP for CLOBETASOL PROPIONATE (CLOBETASOL PROPIONATE)